Nab-TPC vs GP Combined With Camrelizumab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma

Clinical trial NCT06669611 · RECRUITING

Trial details

NCT number: NCT06669611
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Nasopharyngeal Cancinoma (NPC)

Start date: 2024-11-27
Primary completion: 2027-11-20
Enrollment: 242

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.